More black men to benefit from prostate cancer screening trial
Summary
The UK government is expanding a trial to invite tens of thousands more black men aged 45 to 74 for prostate cancer screening. The trial tests new methods alongside the standard PSA blood test to find better ways to detect prostate cancer early in high-risk groups.Key Facts
- More black men in the UK, aged 45-74, will be invited to take part in the prostate cancer screening trial.
- Prostate cancer risk for black men is higher, with one in four likely to develop it, compared to one in eight men overall.
- The trial adds genetic tests and quicker MRI scans to improve screening accuracy beyond the regular PSA test.
- The UK National Screening Committee recommends against regular PSA testing for most men due to possible harms and limited benefits.
- The government is investing £18 million in the Transform trial to support this research and screening expansion.
- Prostate cancer is the most common cancer in UK men, with 64,000 diagnosed and 12,000 deaths yearly.
- Some prostate cancers grow slowly and do not need immediate treatment, which is why widespread screening is not advised.
- Men are encouraged to speak to doctors about testing if they have symptoms like trouble urinating.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.